![]() Precipio Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market. | ![]() CellaVision CellaVision develops and sells digital solutions for blood and body fluids analysis in health care services sector. | ![]() Biolinq Biolinq develops skin-applied electronic sensors that analyze body fluids to provide health information. | |
Founding Date | Founding Date 1997 | Founding Date 1994 | Founding Date 2012 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Omaha, US HQ Glasgow, GB New Haven, US Omaha, US | Locations San Diego, US HQ | |
Employees | Employees 4235% increase | Employees 228 | Employees 1022% decrease |
Valuation ($) | Valuation ($) 9.3 m | Valuation ($) 551.6 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $24m (FY, 2025) | Revenue (est.) kr759m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $13.3m (FY, 2025) | Cost of goods kr224.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $10.7m (FY, 2025) | Gross profit kr534.2m (FY, 2025) | Gross profit N/A |
Net income | Net income ($363k) (FY, 2025) | Net income kr153.1m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 1.5m | Total funding raised N/A | Total funding raised $ 14.8m |

CellaVision develops and sells digital solutions for blood and body fluids analysis in health care services sector.
View company
Biolinq develops skin-applied electronic sensors that analyze body fluids to provide health information.
View company